Wilhelm D, Scheufler E, Peters T
Janssen Research Foundation, Neuss, FRG.
Pharmacology. 1990;41(6):316-26. doi: 10.1159/000138748.
Various calcium-modulating compounds were tested with respect to their protective action against cardiac glycoside toxicity. At the concentrations applied, control force of contraction was reduced by nifedipine and verapamil and slightly attenuated by flunarizine, R 56865, and cimetidine, while it was strongly enhanced by Bay K 8644. The positive inotropic response to ouabain (stimulation rate: 1 Hz) was impaired by nifedipine and verapamil. The increment in contractile force induced by Bay K 8644 was not enhanced by ouabain. The increase in diastolic tension during toxic conditions of ouabain (stimulation rate: 3 Hz) was attenuated by nifedipine, verapamil, bepridil, flunarizine, cimetidine, phenytoin, and R 56865 but not by diltiazem, amiodarone, and amiloride. K loss was prevented by nifedipine, verapamil, diltiazem, bepridil, flunarizine, cimetidine, phenytoin, and R 56865. The increase in cellular Na content was inhibited by R 56865 only. Ca gain was prevented by verapamil, bepridil, flunarizine, R 56865, and cimetidine but not by nifedipine, diltiazem, phenytoin, amiodarone, and amiloride. Ionic deterioration was enhanced by Bay K 8644. These results suggest that pretreatment with various calcium-modulating compounds protects against mechanical and ionic changes during ouabain intoxication induced by Na-Ca overload through different mechanisms.
针对多种钙调节化合物对强心苷毒性的保护作用进行了测试。在所应用的浓度下,硝苯地平和维拉帕米降低了收缩力的对照值,氟桂利嗪、R 56865和西咪替丁使其略有减弱,而Bay K 8644则使其显著增强。硝苯地平和维拉帕米损害了对哇巴因的正性肌力反应(刺激频率:1Hz)。Bay K 8644诱导的收缩力增加并未因哇巴因而增强。在哇巴因毒性条件下(刺激频率:3Hz)舒张张力的增加被硝苯地平、维拉帕米、苄普地尔、氟桂利嗪、西咪替丁、苯妥英和R 56865减弱,但地尔硫䓬、胺碘酮和阿米洛利则没有这种作用。硝苯地平、维拉帕米、地尔硫䓬、苄普地尔、氟桂利嗪、西咪替丁、苯妥英和R 56865可防止钾流失。只有R 56865抑制了细胞内钠含量的增加。维拉帕米、苄普地尔、氟桂利嗪、R 56865和西咪替丁可防止钙增加,但硝苯地平、地尔硫䓬、苯妥英、胺碘酮和阿米洛利则不能。Bay K 8644增强了离子恶化。这些结果表明,用多种钙调节化合物进行预处理可通过不同机制防止哇巴因中毒期间由钠 - 钙超载引起的机械和离子变化。